Annabelle A Okada Selected Research

fosfestrol (Kyorin)

10/2022	Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo.
1/2019	Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
1/2017	Clinical features of uveitis in children and adolescents at a tertiary referral centre in Tokyo.
5/2002	Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annabelle A Okada Research Topics

Disease

16	Macular Degeneration (Age-Related Maculopathy) 07/2022 - 08/2005
13	Inflammation (Inflammations) 01/2021 - 04/2002
11	Uveitis 07/2022 - 05/2002
6	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 02/2022 - 07/2006
6	Retinal Detachment (Retinal Detachments) 01/2022 - 04/2003
5	Polypoidal Choroidal Vasculopathy 01/2022 - 01/2013
5	Behcet Syndrome (Behcet's Syndrome) 08/2020 - 09/2011
4	COVID-19 02/2022 - 06/2020
4	Retinal Perforations 01/2022 - 12/2008
3	Endophthalmitis (Ophthalmia) 01/2019 - 10/2003
2	Cataract (Cataracts) 10/2022 - 10/2003
2	Sarcoidosis (Schaumann Disease) 10/2022 - 07/2022
2	Optic Atrophy 01/2022 - 01/2015
2	Infections 03/2021 - 10/2003
2	Retinal Diseases 03/2021 - 06/2020
2	Scleritis (Episcleritis) 01/2021 - 03/2011
2	Hemangioma (Angioma) 01/2014 - 09/2009
2	Macular Edema 12/2004 - 05/2004
1	Iritis 07/2022
1	Disease Progression 01/2022
1	Atrophy 07/2020
1	Necrosis 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Neoplasms (Cancer) 11/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2018
1	Iridocyclitis 02/2017
1	Cushing Syndrome 02/2017
1	Glaucoma 01/2017
1	Polyps 09/2015
1	Optic Neuritis (Retrobulbar Neuritis) 08/2015
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2015
1	Arteritis 01/2015
1	Hyperemia 01/2015
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2011
1	Neoplasm Metastasis (Metastasis) 01/2011
1	Neovascular Glaucoma 01/2011
1	Panuveitis 02/2010
1	Edema (Dropsy) 01/2010
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 09/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2009
1	Hemangioblastoma 09/2009
1	Vitreous Detachment (Posterior Vitreous Detachment) 08/2005
1	Retinal Vein Occlusion 12/2004

Drug/Important Bio-Agent (IBA)

13	Retinaldehyde (Retinal)IBA 07/2022 - 04/2003
12	afliberceptIBA 07/2022 - 04/2015
9	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022 - 03/2004
5	Infliximab (Remicade)FDA Link 02/2017 - 09/2011
4	fosfestrol (Kyorin)FDA Link 10/2022 - 05/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 06/2020
3	brolucizumabIBA 07/2022 - 01/2021
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2022 - 01/2019
2	Antiviral Agents (Antivirals)IBA 02/2022 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 05/2009
2	Ranibizumab (Lucentis)FDA Link 01/2019 - 01/2013
2	Interleukin-10 (Interleukin 10)IBA 03/2017 - 06/2004
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 08/2015 - 03/2011
2	tamibaroteneIBA 08/2015 - 03/2011
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2015 - 06/2010
2	Bevacizumab (Avastin)FDA Link 01/2011 - 03/2009
2	Triamcinolone (Aristocort)FDA Link 12/2004 - 05/2004
1	Pharmaceutical PreparationsIBA 07/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	LactoferrinIBA 08/2020
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 08/2020
1	EndotoxinsIBA 01/2020
1	dehydroxymethylepoxyquinomicinIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 11/2018
1	MicroRNAs (MicroRNA)IBA 11/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2018
1	betamethasone sodium phosphate FDA LinkGeneric 02/2017
1	Ophthalmic Solutions (Eye Drops)IBA 02/2017
1	GlucocorticoidsIBA 02/2017
1	Biological ProductsIBA 01/2017
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 09/2015
1	N-acetyltryptophanamide (NATA)IBA 01/2013
1	Interferon-gamma (Interferon, gamma)IBA 03/2011
1	RetinoidsIBA 03/2011
1	Vitamin A (Retinol)FDA LinkGeneric 06/2010
1	KIR ReceptorsIBA 02/2010
1	SteroidsIBA 01/2010
1	Inhibins (Inhibin)IBA 09/2009
1	CytokinesIBA 05/2009
1	apilimodIBA 01/2008
1	Interleukin-12 (IL 12)IBA 01/2008

Therapy/Procedure

15	Therapeutics 06/2022 - 05/2002
8	Intravitreal Injections 03/2021 - 10/2003
7	Injections 08/2020 - 09/2015
6	Vitrectomy 10/2022 - 04/2003
2	Oral Administration 01/2008 - 04/2002
1	Personal Protective Equipment 03/2021
1	Immunomodulation 01/2021
1	Antibiotic Prophylaxis 08/2018
1	Remission Induction 02/2017
1	Cataract Extraction 01/2017
1	Light Coagulation 01/2014
1	Induced Hyperthermia (Thermotherapy) 09/2009
1	Lasers (Laser) 08/2005